Sepsis Post Market Observational Study and Potential Reduction of Time to Antibiotics - Baylor S&W
Status
Conditions
Treatments
Details and patient eligibility
About
The purpose of this study is to demonstrate that addition of the Monocyte Width Distribution (MDW) parameter to current standard of care improves a clinician's ability to recognize sepsis in the Emergency Department, resulting in earlier decision to administer antibiotics from time of ED presentation for sepsis patients (simulated primary endpoint), with concomitant reductions in length of stay and in-hospital mortality for those patients (secondary endpoints).
Full description
The objective of this study is to develop a method for identifying sepsis patients from electronic health records (EHR) based on Sepsis-2 criteria. Sepsis patients will be identified using a Sepsis Definition which includes meeting SIRS score of ≥2 within 12 hours of ED presentation and any microbial testing ordered within 24 hours of ED presentation. The patient will be enrolled if it meets the Sepsis Definition and additional EMR data elements will be extracted to complete case report form. Furthermore, objectives include to confirm the clinical validity and performance of MDW in a control population of sepsis patients where MDW is measured but not reported to physicians. This study is an observational study which will simulate the decision impact of MDW on sepsis identification and patient management.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Adult (18 to 89 years)
- All race and ethnicities
- Presenting to the emergency department with suspicion of infection
- Whose assessment includes a CBC with differential
- Meets EMR Sepsis Definition
Exclusion criteria
- Pregnancy
- Prisoners
- Transfers from other ED
- Previously enrolled
Trial design
1,700 participants in 1 patient group
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal